LEXINGTON, Mass. and SINGAPORE, June 4, 2025 /PRNewswire/ -- Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today ...
SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the signing ...
Day One Biopharmaceuticals has announced the appointment of Dr. Michael Vasconcelles as Head of Research & Development, bringing over 25 years of experience in oncology research and corporate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results